CoronavirusCovid-19Health

Johnson & Johnson COVID Vaccine Worth Risk, CDC Says

Taking the Johnson & Johnson coronavirus vaccine, which has come under scrutiny for possible links to heart and neurological conditions, is worth any potential risks, the Centers for Disease Control and Prevention said.

Dr. Hannah Rosenbaum, a CDC researcher, told the agency’s Advisory Committee on Immunization Practices Thursday that the J&J vaccine is secure despite its small number of drawbacks.

“Many hospitalizations, ICU admissions and deaths can be prevented through Janssen and mRNA COVID-19 vaccines, far outweighing the risks,” she said, CNN reported.

Earlier this month, the Food and Drug Administration added a warning to the J&J vaccine, saying it can lead to an increased risk of a rare neurological condition known as Guillain–Barré syndrome.

Though the FDA said such instances are very rare, about 100 suspected cases reportedly have been identified among the nearly 13 million people who have received the shot.

The FDA also temporarily paused the distribution of the Johnson & Johnson vaccine in early April after concerns of a connection to a rare blood clotting condition, but rescinded the order less than two weeks later.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Adblock Detected

Please consider supporting us by disabling your ad blocker